betulinic acid has been researched along with Hepatoblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eichenmüller, M; Kappler, R; von Schweinitz, D | 1 |
1 other study(ies) available for betulinic acid and Hepatoblastoma
| Article | Year |
|---|---|
Betulinic acid treatment promotes apoptosis in hepatoblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Carcinoma, Hepatocellular; Caspase 3; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Hedgehog Proteins; Hep G2 Cells; Hepatoblastoma; Humans; Inhibitor of Apoptosis Proteins; Insulin-Like Growth Factor II; Liver Neoplasms; Microtubule-Associated Proteins; Patched Receptors; Patched-1 Receptor; Pentacyclic Triterpenes; Phosphatidylinositol 3-Kinases; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Receptors, Cell Surface; Signal Transduction; Survivin; Transcription Factors; Triterpenes; Zinc Finger Protein GLI1 | 2009 |